Refine by
Macular Equipment & Supplies
63 equipment items found
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC399 is our proprietary BioSeizer formulation of dexamethasone sodium phosphate (DSP), intended as an intravitreal, or in-eye, injection for the treatment of macular edema due to retinal vein occlusion. TLC399 in preclinical models has been shown to provide therapeutic levels of DSP in the eye for at least six months after a single administration. A Phase I/II safety trial has ...
Manufactured by:Heru, Inc. based inMiami, FLORIDA (USA)
Don’t let age-related macular degeneration (AMD) be your practice’s blind spot. Heru's Market-Leading AMD Portfolio. Heru’s AMD portfolio leverages contrast sensitivity & dark adaptation, which studies have shown may aid physicians in the detection of AMD-related changes up to three years before drusen are visible allowing for earlier intervention and ...
Manufactured by:HEALIOS K.K. based inTokyo, JAPAN
” In the center of the macula is the fovea, 1.5 to 2 mm in diameter, where light entering through the lens is focused, which functions most importantly for visual acuity. Therefore, if macular function is impaired, sufficient visual acuity cannot be obtained even when other regions of the retina are healthy. When an older person experiences vision problems because of an ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 years. ...
Manufactured by:Lutronic Vision based inBillerica, MASSACHUSETTS (USA)
R:GEN is the only retinal laser proven to deliver safe, efficacious and precise targeting of Retinal Pigment Epithelium (RPE) cells. R:GEN’s proprietary Real-Time Feedback, Dual Dosimetry, and Auto Ramp-up technologies ensure precise targeting of RPE cells without damage to ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Age-related macular degeneration (AMD) is a painless eye condition that leads to the gradual loss of central vision and is the most common cause of sight loss in the developed world and the third most common globally. Around 600,000 people in the UK currently have sight loss caused by AMD and around 70,000 new cases are diagnosed every year. Macular degeneration ...
Manufactured by:Reglagene Holding, Inc. based inTucson, ARIZONA (USA)
RGNXXXX is a potent, topical eye drop for the treatment of wet AMD. The anti-neovascular effects reduces leaky blood vessels in the ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment of ocular disorders, including advanced dry age-related macular degeneration (dry AMD) with geographic atrophy (GA) in a transaction ...
Manufactured by:Clearside Biomedical based inAlpharetta, GEORGIA (US) (USA)
FIRST commercial product developed by Clearside; FIRST approved therapeutic delivered into the suprachoroidal space; FIRST therapy for macular edema associated with uveitis; FIRST uveitis trial using visual acuity change as a primary endpoint (Phase 3 ...
Manufactured by:Notal Vision, Inc. based inManassas, VIRGINIA (USA)
The Notal OCT Analyzer (NOATM) is a computational image analysis algorithm designed to provide automated detection of fluid in exudative retinal diseases including wet Age-Related Macular Degeneration, macular edema, and retinal vein occlusions. NOA uses a machine learning algorithm and image recognition computational technique to distinguish between normal ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
The aim of this case study was to evaluate whether the Mimetix scaffold can mimic Bruch’s membrane and assess the attachment, proliferation and differentiation of human RPE cells (ARPE-19) cells within it as a treatment option for age-related macular degeneration. Age-related macular degeneration (AMD) is the most common cause of blindness in the UK, ...
by:AdAlta Limited based inBundoora, AUSTRALIA
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, CXCR4 and demonstrates anti-fibrotic effects in several models of fibrosis. This was initially called AD-114. Following further development, AdAlta ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
HLX04-O, recombinant anti-VEGF humanised monoclonal antibody injection. It is indicated for wet age-related macular degeneration (wAMD). HLX04-O was granted Phase 3 clinical study approvals in Australia, the United States, Singapore and the EU countries such as Latvia, Hungary and Spanish. In April 2022, the first patient in Australia and Latvia was dosed in the global ...
Manufactured by:Notal Vision, Inc. based inManassas, VIRGINIA (USA)
A home-based monitoring program supporting earlier detection of wet AMD in intermediate dry AMD patients. FDA-Cleared and Covered by Medicare and Most Private Insurance. The progression from dry Age-related Macular Degeneration (AMD) to wet AMD can occur rapidly and lead to severe vision loss if left undiagnosed and untreated. ForeseeHome® allows physicians to detect wet AMD ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
UBX1325 is an Bcl-xL inhibitor that promotes apoptosis in senescent cells. UBX1325 is a potent anti-aging agent that can be used in studies of age-related eye diseases such as diabetic macular oedema (DME), age-related macular degeneration (AMD) and diabetic retinopathy ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular Degeneration (Wet-AMD). Patients affected by these diseases share common symptoms, such as blurriness in vision and progressive vision loss as the disease ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU410 (AAV-RORA) is a modifier gene therapy product candidate being developed for the treatment of dry age-related macular degeneration (Dry AMD). OCU410 utilizes an AAV delivery platform for the retinal delivery of the RORA (RAR Related Orphan Receptor A) gene. Various genes associated with AMD are regulated by RORA. The RORA protein plays an important role in lipid metabolism ...
Manufactured by:Digital Diagnostics Inc. based inCoralville, IOWA (USA)
IDx-DR is an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy (including macular ...
by:UNITY Biotechnology based inSouth San Francisco, CALIFORNIA (USA)
UBX1325, a potent Bcl-xL inhibitor, is in clinical development for the treatment of age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), and diabetic retinopathy (DR). UBX1325 is designed to selectively eliminate the senescent cells accumulating in diseased blood vessels of the eye. This novel approach ...